Managing Comorbid Tobacco Use Disorder for Individuals With Schizophrenia: Challenges and Opportunities
The DOI matches its Crossref record; 6 of the 7 references it cites were found in a registry or an index.
Abstract
Smoking and tobacco use disorder (TUD) is highly prevalent among individuals with serious and persistent mental illness, particularly those with schizophrenia spectrum disorders. In this clinical case column, we highlight an encounter involving a successful initiation of bupropion for smoking cessation in an individual with schizophrenia. We also review the relevant literature around the epidemiology of TUD among people with schizophrenia, highlight the increased complications and mortality secondary to TUD, and discuss relevant strategies for clinicians to support individuals with serious and persistent mental illness aiming to reduce or stop their tobacco consumption. Le tabagisme et le trouble de l’usage du tabac (TUT) sont très répandus chez les personnes souffrant de maladies mentales graves et persistantes (MMGP), en particulier celles atteintes de troubles du spectre de la schizophrénie. Dans cette chronique de cas cliniques, nous mettons en évidence une rencontre impliquant une initiation réussie du bupropion pour le sevrage tabagique chez une personne atteinte de schizophrénie. Nous passons également en revue la littérature pertinente concernant l'épidémiologie du TUT chez les personnes atteintes de schizophrénie, soulignons l’augmentation des complications et de la mortalité secondaires au TUT, et discutons des stratégies pertinentes pour les cliniciens afin de soutenir les personnes atteintes de MMGP visant à réduire ou à arrêter leur consommation de tabac.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Anthenelli, R. M., Benowitz, N. L., West, R., St Aubin, L., McRae, T., Lawrence, D., Ascher, J., Russ, C., Krishen, A., & Evins, A. E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30272-0 · Cited by 1,177
Change in mental health after smoking cessation: systematic review and meta-analysis
Taylor, G., McNeill, A., Girling, A., Farley, A., Lindson-Hawley, N., & Aveyard, P. (2014) · BMJ · doi:10.1136/bmj.g1151 · Cited by 1,039
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report
Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J., et al. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802443569 · Cited by 735
Callaghan, R. C., Veldhuizen, S., Jeysingh, T., Orlan, C., Graham, C., Kakouris, G., Remington, G., & Gatley, J. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.09.014 · Cited by 255
Soulakova, J. N., & Crockett, L. J. (2016) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntw273 · Cited by 58
Evins, A. E., West, R., Benowitz, N. L., Russ, C., Lawrence, D., McRae, T., Maravic, M. C., Heffner, J. L., & Anthenelli, R. M. (2021) · Psychiatric Services · doi:10.1176/appi.ps.202000032 · Cited by 39
Cited by
Bahji, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040999 · Cited by 83
Self-citation
Metadata
- Authors
- Dhaliwal, A. K., Bahji, A., & Danilewitz, M.
- Affiliations
- Western University (CA)
- University of Calgary (CA)
- University of Toronto (CA)
- Venue
- Canadian Journal of Addiction
- Published
- 2022-12
- Volume
- 13
- Issue
- 4
- Pages
- 53-55
- ISSN
- 2368-4720 (ISSN-L)
- 2368-4739
- OpenAlex
- W4385820720
- Cited by
- 1
- References
- 7
- Citations by year
- 2024: 1
- FWCI
- 0.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Canadian Journal of Addiction (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- tobacco use disorder, schizophrenia, smoking cessation, bupropion, comorbidities, serious and persistent mental illness, smoking-related mortality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Managing Comorbid Tobacco Use Disorder for Individuals With Schizophrenia: Challenges and Opportunities. https://app.cochat.ai/papers/10.1097/cxa.0000000000000164
- The paper
- Dhaliwal, A. K., Bahji, A., & Danilewitz, M. (2022). Managing Comorbid Tobacco Use Disorder for Individuals With Schizophrenia: Challenges and Opportunities. Canadian Journal of Addiction. https://doi.org/10.1097/cxa.0000000000000164
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.